Wholesale of pharmaceutical and medical goods
BIOMERIEUX NORGE AS
Revenue 2024
NOK 74.3m
Operating profit
NOK 3.6m
Equity
NOK 6.4m
Incorporated
1999
Share capital
NOK 2.8m
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 74.3m | |
| Total operating costs | 70.7m | |
| Operating profit (EBIT) | 3.6m | |
| Net financial items | 253k | |
| Profit for the year | 3.1m |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 22.6m | |
| of which current assets | 17.9m | |
| Equity | 6.4m | |
| Total liabilities | 16.2m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.